 Deferoxamine
"Deferoxamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
| Descriptor ID |
D003676
|
| MeSH Number(s) |
D02.092.570.394.265 D02.241.511.372.265
|
| Concept/Terms |
Deferoxamine- Deferoxamine
- Deferoximine
- Desferroxamine
- Desferioximine
- Desferrioxamine
- Desferrioxamine B
- B, Desferrioxamine
- Deferoxamine B
- B, Deferoxamine
- Deferrioxamine B
Desferrioxamine B Mesylate- Desferrioxamine B Mesylate
- Mesylate, Desferrioxamine B
- Deferoxamine Mesylate
- Mesylate, Deferoxamine
- Deferoxamine Methanesulfonate
- Methanesulfonate, Deferoxamine
- Deferoxamine Mesilate
- Mesilate, Deferoxamine
|
Below are MeSH descriptors whose meaning is more general than "Deferoxamine".
Below are MeSH descriptors whose meaning is more specific than "Deferoxamine".
This graph shows the total number of publications written about "Deferoxamine" by people in this website by year, and whether "Deferoxamine" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1986 | 1 | 0 | 1 | | 1988 | 0 | 1 | 1 | | 1989 | 0 | 3 | 3 | | 1990 | 1 | 0 | 1 | | 1993 | 1 | 1 | 2 | | 1994 | 1 | 1 | 2 | | 1995 | 1 | 0 | 1 | | 1996 | 1 | 0 | 1 | | 2006 | 0 | 1 | 1 | | 2007 | 0 | 1 | 1 | | 2008 | 0 | 1 | 1 | | 2011 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Deferoxamine" by people in Profiles.
-
Kanojia D, Zhou W, Zhang J, Jie C, Lo PK, Wang Q, Chen H. Proteomic profiling of cancer stem cells derived from primary tumors of HER2/Neu transgenic mice. Proteomics. 2012 Nov; 12(22):3407-15.
-
Yuan G, Khan SA, Luo W, Nanduri J, Semenza GL, Prabhakar NR. Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia. J Cell Physiol. 2011 Nov; 226(11):2925-33.
-
Garcia AJ, Khan SA, Kumar GK, Prabhakar NR, Ramirez JM. Hydrogen peroxide differentially affects activity in the pre-Bötzinger complex and hippocampus. J Neurophysiol. 2011 Dec; 106(6):3045-55.
-
Zieger MA, Gupta MP. Hypothermic preconditioning of endothelial cells attenuates cold-induced injury by a ferritin-dependent process. Free Radic Biol Med. 2009 Mar 01; 46(5):680-91.
-
Tracy K, Dibling BC, Spike BT, Knabb JR, Schumacker P, Macleod KF. BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol Cell Biol. 2007 Sep; 27(17):6229-42.
-
Zieger MA, Gupta MP. Endothelial cell preservation at 10 degrees C minimizes catalytic iron, oxidative stress, and cold-induced injury. Cell Transplant. 2006; 15(6):499-510.
-
Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM, Schumacker PT. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem. 2000 Aug 18; 275(33):25130-8.
-
Spencer KT, Lindower PD, Buettner GR, Kerber RE. Transition metal chelators reduce directly measured myocardial free radical production during reperfusion. J Cardiovasc Pharmacol. 1998 Sep; 32(3):343-8.
-
Demling R, LaLonde C, Ikegami K. Fluid resuscitation with deferoxamine hetastarch complex attenuates the lung and systemic response to smoke inhalation. Surgery. 1996 Mar; 119(3):340-8.
-
Fijan S, Hönigsmann H, Ortel B. Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine. Br J Dermatol. 1995 Aug; 133(2):282-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|